{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:44:37Z","timestamp":1791233077328,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100019588","name":"Plum Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019588","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Erwin Rautenberg Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Systemic sclerosis (SSc) is a rare connective tissue disease, frequently affecting the skin, lungs, and pulmonary vasculature. Approximately 30\u201350% of SSc patients develop interstitial lung disease (SSc-ILD), with 30\u201335% of related deaths attributed to it. Even though men are less likely to develop systemic sclerosis, they have a higher incidence of SSc-ILD than women, and they tend to develop it at a younger age with a higher mortality rate. Sex differences in protein expression in the blood of patients with SSc-ILD have not been reported to date. We aimed to identify sex differences in serum protein expression between men and women with SSc-ILD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Serum specimens of patients with SSc-ILD underwent dual mass spectrometry (LC-MS\/MS) analysis. The association between protein biomarkers and sex was assessed through logistic regression. Time to event analysis was performed to determine any differences in the time to FVC decline of &gt;\u20095% and the proportion of subjects who experienced FVC decline of &gt;\u20095% by sex over the total period of observation. The association between biomarkers and sex was assessed through logistic regression. For proteins that were dichotomized, chi-squared testing was used. Multivariable regression models adjusting for meaningful clinical variables were also performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The cohort consisted of 211 subjects, 162 women and 47 men with a median follow-up of 3.52 years. No significant sex differences were found in the time to FVC decline of &gt;\u20095% or &gt;\u200910%. Among the 704 proteins identified, forty differed significantly between sexes. After adjusting for multiple testing, Autotaxin remained significantly higher in women. Autotaxin, known to activate lysophosphatidic acid and promote fibrosis, suggests a potential role in modulating fibrotic processes in SSc-ILD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This study is the first to report sex-specific serum protein differences in patients with SSc-ILD, with Autotaxin remaining significantly different after adjusting for multiple testing. These proteins could influence disease progression and treatment response and underscore the importance of personalized therapeutic strategies and further research into sex-related molecular pathways in SSc-ILD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Clinical trial number<\/jats:title>\n            <jats:p>Not applicable.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12890-024-03474-z","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T07:24:20Z","timestamp":1736753060000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["An exploratory analysis of differences in serum protein expression by sex in patients with systemic sclerosis associated interstitial lung disease"],"prefix":"10.1186","volume":"25","author":[{"given":"Giuliana","family":"Cerro-Chiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Ayres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra","family":"Mastali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Van Eyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Wolters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Boin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanzira","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,13]]},"reference":[{"issue":"1","key":"3474_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12931-019-0980-7","volume":"20","author":"V Cottin","year":"2019","unstructured":"Cottin V, Brown KK. Interstitial lung disease associated with systemic sclerosis (SSc-ILD). Respir Res. 2019;20(1):13.","journal-title":"Respir Res"},{"issue":"2","key":"3474_CR2","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.semarthrit.2017.03.019","volume":"47","author":"V Hax","year":"2017","unstructured":"Hax V, Bredemeier M, Didonet Moro AL, Pavan TR, Vieira MV, Pitrez EH, et al. Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis. Semin Arthritis Rheum. 2017;47(2):228\u201334.","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"3474_CR3","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.rdc.2014.12.005","volume":"41","author":"SR Schoenfeld","year":"2015","unstructured":"Schoenfeld SR, Castelino FV. Interstitial lung disease in scleroderma. Rheum Dis Clin North Am. 2015;41(2):237\u201348.","journal-title":"Rheum Dis Clin North Am"},{"issue":"2","key":"3474_CR4","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s11926-010-0095-0","volume":"12","author":"D Strollo","year":"2010","unstructured":"Strollo D, Goldin J. Imaging lung disease in systemic sclerosis. Curr Rheumatol Rep. 2010;12(2):156\u201361.","journal-title":"Curr Rheumatol Rep"},{"key":"3474_CR5","doi-asserted-by":"publisher","first-page":"152366","DOI":"10.1016\/j.semarthrit.2024.152366","volume":"65","author":"C Sieiro Santos","year":"2024","unstructured":"Sieiro Santos C, Antolin SC, Lorenzo JC, Garay CL, Morales CM, de Miguel EB, et al. KL6 and IL-18 levels are negatively correlated with respiratory function tests and ILD extent assessed on HRCT in patients with systemic sclerosis-related interstitial lung disease (SSc-ILD). Semin Arthritis Rheum. 2024;65:152366.","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"3474_CR6","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s12016-013-8392-9","volume":"47","author":"F D\u2019Amico","year":"2014","unstructured":"D\u2019Amico F, Skarmoutsou E, Mazzarino MC. The sex bias in systemic sclerosis: on the possible mechanisms underlying the female disease preponderance. Clin Rev Allergy Immunol. 2014;47(3):334\u201343.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"7","key":"3474_CR7","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1093\/rheumatology\/keac660","volume":"62","author":"C Campochiaro","year":"2023","unstructured":"Campochiaro C, Hoffmann-Vold AM, Avouac J, Henes J, de Vries-Bouwstra J, Smith V, et al. Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: a EUSTAR database analysis. Rheumatology (Oxford). 2023;62(7):2483\u201391.","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"3474_CR8","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1093\/rheumatology\/kez486","volume":"59","author":"VK Jaeger","year":"2020","unstructured":"Jaeger VK, Tikly M, Xu D, Siegert E, Hachulla E, Airo P, et al. Racial differences in systemic sclerosis disease presentation: a European scleroderma trials and Research group study. Rheumatology (Oxford). 2020;59(7):1684\u201394.","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"3474_CR9","doi-asserted-by":"publisher","first-page":"e668","DOI":"10.1016\/S2665-9913(22)00193-X","volume":"4","author":"ER Volkmann","year":"2022","unstructured":"Volkmann ER, Tashkin DP, Silver R, Bostwick CF, Assassi S, Frost DB, et al. Sex differences in clinical outcomes and biological profiles in systemic sclerosis-associated interstitial lung disease: a post-hoc analysis of two randomised controlled trials. Lancet Rheumatol. 2022;4(10):e668\u201378.","journal-title":"Lancet Rheumatol"},{"issue":"11","key":"3474_CR10","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65(11):2737\u201347.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"3474_CR11","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1093\/clinchem\/hvab202","volume":"68","author":"A Mc Ardle","year":"2022","unstructured":"Mc Ardle A, Binek A, Moradian A, Chazarin Orgel B, Rivas A, Washington KE, et al. Standardized workflow for Precise Mid- and high-throughput proteomics of blood biofluids. Clin Chem. 2022;68(3):450\u201360.","journal-title":"Clin Chem"},{"issue":"1","key":"3474_CR12","doi-asserted-by":"publisher","first-page":"8645","DOI":"10.1038\/s41598-023-35840-y","volume":"13","author":"G Cerro-Chiang","year":"2023","unstructured":"Cerro-Chiang G, Ayres M, Rivas A, Romero T, Parker SJ, Mastali M, et al. Protein biomarkers of disease progression in patients with systemic sclerosis associated interstitial lung disease. Sci Rep. 2023;13(1):8645.","journal-title":"Sci Rep"},{"issue":"4","key":"3474_CR13","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1183\/09031936.00155108","volume":"35","author":"CJ Zappala","year":"2010","unstructured":"Zappala CJ, Latsi PI, Nicholson AG, Colby TV, Cramer D, Renzoni EA, et al. Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis. Eur Respir J. 2010;35(4):830\u20136.","journal-title":"Eur Respir J"},{"key":"3474_CR14","doi-asserted-by":"crossref","unstructured":"Distler O, Assassi S, Cottin V, Cutolo M, Danoff SK, Denton CP et al. Predictors of progression in systemic sclerosis patients with interstitial lung disease. Eur Respir J. 2020;55(5).","DOI":"10.1183\/13993003.02026-2019"},{"key":"3474_CR15","unstructured":"Hoffmann-Vold A-M, Midtvedt O, Garen T, Lund MB, Aalokken TM, Gran JT, et al. editors. Moderate decline in forced vital capacity is associated with a poor outcome in systemic sclerosis patients. Arthritis & Rheumatology; 2014: Wiley-Blackwell 111 River St, Hoboken 07030\u2009\u2013\u20095774, NJ USA."},{"issue":"3","key":"3474_CR16","first-page":"228","volume":"32","author":"B Kennedy","year":"2015","unstructured":"Kennedy B, Branagan P, Moloney F, Haroon M, O\u2019Connell OJ, O\u2019Connor TM, et al. Biomarkers to identify ILD and predict lung function decline in scleroderma lung disease or idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis. 2015;32(3):228\u201336.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"5","key":"3474_CR17","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1164\/rccm.201709-1845OC","volume":"197","author":"S Kafaja","year":"2018","unstructured":"Kafaja S, Clements PJ, Wilhalme H, Tseng CH, Furst DE, Kim GH, et al. Reliability and minimal clinically important differences of forced vital capacity: results from the Scleroderma Lung studies (SLS-I and SLS-II). Am J Respir Crit Care Med. 2018;197(5):644\u201352.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"3474_CR18","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1165\/rcmb.2010-0155OC","volume":"46","author":"M Funke","year":"2012","unstructured":"Funke M, Zhao Z, Xu Y, Chun J, Tager AM. The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injury. Am J Respir Cell Mol Biol. 2012;46(3):355\u201364.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"3474_CR19","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1165\/rcmb.2012-0004OC","volume":"47","author":"N Oikonomou","year":"2012","unstructured":"Oikonomou N, Mouratis MA, Tzouvelekis A, Kaffe E, Valavanis C, Vilaras G, et al. Pulmonary autotaxin expression contributes to the pathogenesis of pulmonary fibrosis. Am J Respir Cell Mol Biol. 2012;47(5):566\u201374.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"3474_CR20","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.1038\/s41598-017-03701-0","volume":"7","author":"D Missirlis","year":"2017","unstructured":"Missirlis D, Haraszti T, Kessler H, Spatz JP. Fibronectin promotes directional persistence in fibroblast migration through interactions with both its cell-binding and heparin-binding domains. Sci Rep. 2017;7(1):3711.","journal-title":"Sci Rep"},{"issue":"1","key":"3474_CR21","doi-asserted-by":"publisher","first-page":"138","DOI":"10.4049\/jimmunol.161.1.138","volume":"161","author":"S Marazzi","year":"1998","unstructured":"Marazzi S, Blum S, Hartmann R, Gundersen D, Schreyer M, Argraves S, et al. Characterization of human fibroleukin, a fibrinogen-like protein secreted by T lymphocytes. J Immunol. 1998;161(1):138\u201347.","journal-title":"J Immunol"},{"issue":"10","key":"3474_CR22","doi-asserted-by":"publisher","first-page":"e668","DOI":"10.1016\/S2665-9913(22)00193-X","volume":"4","author":"ER Volkmann","year":"2022","unstructured":"Volkmann ER, Tashkin DP, Silver R, Bostwick CF, Assassi S, Baker Frost D, et al. Sex differences in clinical outcomes and biological profiles in systemic sclerosis-associated interstitial lung disease: a post-hoc analysis of two randomised controlled trials. Lancet Rheumatol. 2022;4(10):e668\u201378.","journal-title":"Lancet Rheumatol"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-024-03474-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-024-03474-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-024-03474-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:53:59Z","timestamp":1751360039000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-024-03474-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,13]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3474"],"URL":"https:\/\/doi.org\/10.1186\/s12890-024-03474-z","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,13]]},"assertion":[{"value":"20 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been updated to amend the license information.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"this study was approved by the Internal Review Board of the University of California San Francisco.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}